The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations.
Finding top talent in the hyper-competitive life science industries gets harder each day. With thousands of resources worldwide, hundreds of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee.
Get direct access to the specialized life science talent you need to bring products to market and keep them there. Whether you’re looking for consulting or project support, full-time contract, contract-to-hire, or direct-hire talent, we rapidly identify the right resource, the first time.
Build or augment your Quality Assurance team with top talent or outsource projects to an expert third party. We help thousands of life science companies find specialized resources and drive their projects to completion on-time and on-budget.
Develop and submit applications alongside former FDA and industry experts or fill in-house roles with select talent.
Maximize cost-effectiveness, flexibility, and scalability when building a partial or full in-house clinical operations team through rapid, reliable access to experienced clinical experts.
We are that partner. We help thousands of firms within the FDA-regulated industries find the resources they need, when and where they need them, through the optimal workforce model.
At The FDA Group, we're committed to providing exceptional services backed by our Total Quality Guarantee. If, for any reason, you are dissatisfied with our services, we will provide a full refund.
Since 2007, we've been documenting and excluding consultants who don't meet our high standards—protecting your projects from poor performance, lack of integrity, and slow response times. By suppressing these consultants from client engagements, we maintain a network of top-tier professionals that consistently deliver exceptional results.
Talk to us when you're ready for a better talent resourcing experience and the peace of mind that comes with a partner whose commitment to quality and integrity reflects your own.
The FDA's April 2024 Final Rule marks a pivotal shift in the regulation of Laboratory-Developed Tests, categorizing them under in vitro diagnostics and subjecting them to medical device regulations. Labs need to adapt to a new regulatory landscape where compliance, innovation, and patient safety intersect.
Our team, comprising industry veterans and ex-FDA staff, offers unmatched expertise to help you assess your current state of compliance against these new rules and guide you through a compliance assurance project.